earnings
confidence high
sentiment negative
materiality 0.85
Inspire Medical Q2 net loss $3.6M, cuts FY 2025 revenue guidance to $900-910M
Inspire Medical Systems, Inc.
2025-Q2 EPS reported
-$0.02
revenue$418,403,000
- Q2 revenue $217.1M (+11% YoY), net loss $3.6M vs prior year net income $9.8M.
- Adjusted diluted EPS $0.45; GAAP diluted loss per share $0.12.
- FY 2025 revenue guidance cut to $900-910M (prior $940-955M); EPS cut to $0.40-0.50 from $2.20-2.30.
- Full U.S. launch of Inspire V neurostimulation system initiated.
- EVP Randall Ban to retire on January 30, 2026.